Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delacon is an Austria-based animal nutrition company focused on phytogenic feed additives for livestock and aquaculture. The company develops and manufactures standardized plant-based products made from bioactive compounds such as essential oils, flavonoids, and saponins to support animal health, performance, and well-being. Its commercial portfolio addresses poultry, swine, ruminants, and aquaculture, with applications in digestive health, feed efficiency, resilience, and sustainability. Delacon has a strong R&D orientation, including industry-owned phytogenic research capabilities and product technologies such as traceability analytics and heat-resistant micro-encapsulation. Since 2022, Delacon has been fully owned by Cargill and operates as part of Cargill's animal nutrition business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delacon.